Microemulsion Gels of Tapentadol Hydrochloride: Statistical Analysis of Pharmacokinetics and Skin Irritation Studies.

Q1 Pharmacology, Toxicology and Pharmaceutics
Nanotheranostics Pub Date : 2025-05-07 eCollection Date: 2025-01-01 DOI:10.7150/ntno.110819
Nimmathota Madhavi, Naveen Kumar Ganji, Heera Battu, Beeravelli Sudhakar
{"title":"Microemulsion Gels of Tapentadol Hydrochloride: Statistical Analysis of Pharmacokinetics and Skin Irritation Studies.","authors":"Nimmathota Madhavi, Naveen Kumar Ganji, Heera Battu, Beeravelli Sudhakar","doi":"10.7150/ntno.110819","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The present study aimed to overcome the drawbacks of tapentadol through the oral route and to assess the significance of microemulsion gels for transdermal delivery via pharmacokinetic approach. <b>Methods:</b> Microemulsions were prepared via a ternary phase diagram. The optimized microemulsion was converted into gels, and the microemulsion was evaluated for particle size, zeta potential and cumulative <i>in vitro</i> drug release, whereas the gel was characterized for viscosity, spreadability, <i>in vitro</i>, <i>ex vivo</i>, <i>in vivo</i> and skin irritation studies. The prepared ME-gel PKs were tested against MEs, oral solution and plain gel. <b>Results:</b> The PK study revealed that the half-life of the ME gel was 2.2-fold greater than that of the oral solution and 1.65-fold greater than that of the plain gel. The MRT of the ME gel was 6-fold greater than that of the oral solution and 3.3-fold greater than that of the plain gel. The overall mean value of the AUC (0-∞) was 3.16 times greater than that of the oral route. The skin irritation studies found that absence of irritation and damage after application of ME-gel. <b>Conclusion:</b> The PK study revealed that ME-gel was effective in pain management. The level A IVIVC between the <i>in vitro</i> fraction of drug released and the fraction of drug absorbed <i>in vivo</i> was 0.9731.</p>","PeriodicalId":36934,"journal":{"name":"Nanotheranostics","volume":"9 2","pages":"144-154"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12188534/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanotheranostics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7150/ntno.110819","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The present study aimed to overcome the drawbacks of tapentadol through the oral route and to assess the significance of microemulsion gels for transdermal delivery via pharmacokinetic approach. Methods: Microemulsions were prepared via a ternary phase diagram. The optimized microemulsion was converted into gels, and the microemulsion was evaluated for particle size, zeta potential and cumulative in vitro drug release, whereas the gel was characterized for viscosity, spreadability, in vitro, ex vivo, in vivo and skin irritation studies. The prepared ME-gel PKs were tested against MEs, oral solution and plain gel. Results: The PK study revealed that the half-life of the ME gel was 2.2-fold greater than that of the oral solution and 1.65-fold greater than that of the plain gel. The MRT of the ME gel was 6-fold greater than that of the oral solution and 3.3-fold greater than that of the plain gel. The overall mean value of the AUC (0-∞) was 3.16 times greater than that of the oral route. The skin irritation studies found that absence of irritation and damage after application of ME-gel. Conclusion: The PK study revealed that ME-gel was effective in pain management. The level A IVIVC between the in vitro fraction of drug released and the fraction of drug absorbed in vivo was 0.9731.

Abstract Image

Abstract Image

Abstract Image

盐酸他他多微乳凝胶:药代动力学统计分析及皮肤刺激研究。
背景:本研究旨在克服他他多口服给药的缺点,并通过药代动力学方法评价微乳凝胶在经皮给药中的意义。方法:采用三元相图法制备微乳。将优化后的微乳液转化为凝胶,对微乳液的粒径、zeta电位和体外累积药物释放进行了评价,并对凝胶的粘度、涂抹性、体外、离体、体内和皮肤刺激性进行了表征。将制备的me凝胶PKs与MEs、口服溶液和普通凝胶进行对比。结果:PK研究显示,ME凝胶的半衰期比口服溶液长2.2倍,比普通凝胶长1.65倍。ME凝胶的MRT比口服溶液高6倍,比普通凝胶高3.3倍。总体AUC均值(0-∞)是口腔路径的3.16倍。皮肤刺激性研究发现,使用me凝胶后,皮肤无刺激性和损伤。结论:药代动力学研究表明,me -凝胶治疗疼痛有效。药物体外释放分数与体内吸收分数的A级IVIVC值为0.9731。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nanotheranostics
Nanotheranostics Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
CiteScore
10.40
自引率
0.00%
发文量
37
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信